This was in 2005. Dr. Fauci knew then HydroxyChloroQuine was effective against Covid type viruses. “In the 1985-86 edition of Harrison’s Principles of Internal Medicine [a highly recommended book for students studying medicine in medical colleges], Dr. Fauci wrote that HCQ worked an anti-viral agent despite being an anti-malarial drug. There was no Covid-19 back then, but HCQ’s anti-viral properties were already well known.
In 2015 the only level-4 virus lab in the U.S. conducting defensive research against “Gain of function” viruses was closed because of the inherent danger to the population should the virus escape. Not to worry, President Obama, Melinda Gates and Dr Fauci started to look for a new place to conduct the research. They found it in Wuhan, China; the Chinese have no such scruples as danger to the people. This lab was taken over in 2017 by the Chinese army, conducting bio-weapon research (defensive only, of course), so the research continued, this time controlled by the Chinese.
In January 2017 Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, said there is “no doubt” Donald J. Trump will be confronted with a surprise infectious disease outbreak during his presidency.
It is getting interesting. The virus escaped the lab, sometimes in the fall of 2019, and the Chinese knew it but kept silent. They closed off Wuhan to all other Chinese, rail, car and air. But they kept international travel open, as if they wanted the virus to spread all around the world. And Dr. Fauci knew it!
Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure.
Hydroxychloroquine, the malaria drug touted as a magical Covid-19 cure by former US President Donald Trump last year, has been found effective in a prophylactic study published in a prophylactic study published in the Journal of The Association of Physicians of India (JAPI) last week..
The study showed that hydroxychloroquine, popularly known as HCQ, could prevent SARS-CoV-2 infection in varying degrees depending on its dosing regimen. The highest prevention rate of 72 per cent was found among those given hydroxychloroquine over six weeks or a longer duration.
The study said, “[W]hen adjusted for other risk factors, HCQ dose as per government recommendations, 2-3, 4-5, 6 or more weeks reduced the probability of Covid positivity by 34 per cent, 48 per cent and 72 per cent.”
The study was conducted May-September last year when HCQ was still part of the Union health ministry’s recommendation in treatment protocol for Covid-19, and it began against the backdrop of contesting claims made by authorities and experts including Donald Trump and his advisor Dr Anthony Fauci, the US’s top infectious disease expert.
In March 2020, Donald Trump declared that hydroxichloroquine was a “game changer” drug in the fight against Covid-19. Dr Fauci dismissed the claim citing lack of study and evidence. Despite Fauci’s counter-positioning, Trump continued to be vocal about taking HCQ as prophylactic drug.
Incidentally, the Union health ministry on June 6 dropped hydroxychloroquine from Covid-19 treatment protocol. In its nine-page guidelines released on Sunday (June 6) by the directorate of health services, hydroxychloroquine, ivermectin and favipiravir find no mention.
The government’s decision came on the back of criticism by experts who pointed out a lack of study-based evidence to recommend hydroxychloroquine in Covid-19 cases. The government’s revised guidelines, however, contradicts the recommendations made by the Indian Council of Medical Research as released on May 17.
The ICMR guidelines prescribed the use of hydroxychloroquine in mild cases of Covid-19.
The authors of this prophylactic (relating to prevention of a disease) study said that this “is the largest multicenter study on HCQ prophylaxis on HCWs (healthcare workers), covering over 12,000 HCWs at the risk of Covid-19”.
The study was conducted in May-September last year across 44 hospitals in 17 states involving hundreds of doctors, who received doses of hydroxychloroquine.
One of the co-authors of the study, Dr Raj Kamal Choudhry said, “In the 1985-86 edition of Harrison’s Principles of Internal Medicine [a highly recommended book for students studying medicine in medical colleges], Dr. Fauci wrote that HCQ worked an anti-viral agent despite being an anti-malarial drug. There was no Covid-19 back then, but HCQ’s anti-viral properties were already well known.”
Dr Raj Kamal Choudhry, who was the nodal officer for the prophylaxis study of HCQ in Bihar’s Bhagalpur medical college, said, “We had given about 2,700 doctors and paramedical staff, laundry and kitchen people the prophylaxis of HCQs in the dose of HCQs 400 mg 1×2 for first day then 1 tab daily for 4 days.”
“We did not give to those who had palpitations and had QT prolongation [a measure of heart ailment]. Those who took this drug did not have Covid excepting 5 and 6. The effect was tremendous. Later, we gave this drug to all who had mild cases. Only those patients who were in ICU were not given.”
“Of 2,700 people who were given HCQs, 700 were doctors. Only five or six got infected with SARS-CoV-2 in Bhagalpur but none developed serious complications, and nobody died of Covid-19,” Dr Raj Kamal Choudhry told Indiatoday.in.
The evidence is piling up. There has been numerous, over 50 studies like this showing that HCQ is effective, both as prophylactic, and as an early cure. Yoo bad that the medical bureaucracy considered it more important to get rid of Donald Trump than to save over 100,000 lives in U.S. alone.
In addition HCQ is too cheap and generic to warrant a double blind study.
The other medication that may be as effective, and save lives is Ivermectin, an anti-parasite drug used to treat horses and other farm animals. You can buy it at Tractor Supply, so I have been told. I do not know proper dosages, but if done properly, it is safe for humans when treating parasitic infections. It also is too cheap for the medical community to take seriously.
One more thing, make sure you take supplemental Vitamin D3 (I take 5000 IU/day). An Indonesian study found that the death rate went from 95% if the values were less than 19 nanograms/milliliter to less than 5% if the D3 values were over 31 nanograms/milliliter. The study was made in Covid patients over 65 years old.
I have counted the u.s covid-19 cases cases and deaths for the first week of April, and divided them by states requiring mask wearing and not requiring wearing masks. The mask wearing states had a death rate of 0.91% while the non mask wearing states had a death rate of 1.59%. The non mask wearing states had 244 deaths per day. This means we could have saved 244 (1.59-0,91)/1.59 = 103 lives per day as a nation if all were forced to wear a mask, everything else being equal (which of course it isn’t). (Look at Appendix 1 to see how your state is faring.)
Are there any better ways to save lives?
In March 2020 President Trump became a proponent of using HydroxyChloroQuine as a remedy for Covid-19. It was met with strong opposition from CDC and even scorn from his political opponents. CDC even published strong advice against using it to treat Covid-19, while still recommending its use to treat Lupus and rheumatoid patients with essentially no restrictions, including pregnant women and nursing mothers. After all, it had an over 50 year safety record as treatment for Malaria. Even Dr Fauci acknowledged its safety and efficacy as a cure for Coronaviruses as early as 2005, (see Appendix 2). Many countries are using HCQ as a first defense against COVID-19, and they experience on average less than half the death rate of nations that do not use HCQ as a first defense. To complicate matters, HCQ is prescribed to between 16 and 30% of all Covid cases in the U.S. As a guess with today’s 491 death’s per day, we could have saved more than 40%, about 200 lives a day, or twice as many lives as are saved by the mask mandate. The biggest problem for CDC is that HCQ is generic, cheap and easy to produce, so there is no profit in making a double blind study. For Trump opponents it was far more important to defeat Trump than to save a hunded thousand lives. ( see https://lenbilen.com/2020/09/06/u-s-a-corona-virus-death-rate-as-of-september-5-is-3-00-41-countries-have-higher-death-rates-15-countries-giving-hcqzincz-pac-to-covid-19-patients-as-soon-as-symptoms-occur-have-much-lower-death/ )
But there are other interesting cures for COVID-19, Ivermectin is fantastic. It has one problem, through.You can buy it at Tractor-supply, it is used as an antiparasitic agent for dogs and horses, and it is generic. However the worldwide interest is so big that at least 50 trials have been conducted and there is a 76% decrease in mortality. That means,using it properly would save nearly 400 lives per day.
This article needs wide distribution. It is eye-opening, showing clearly the Chinese origin and intent with the China-virus. It also shows the difficulty in developing a universal vaccine against it; it may never succeed. This means we may have to live through the pandemic until herd immunity is established, like Sweden has been doing. The solution is to concentrate on therapeutics, and the .minimum we should do is to immediately release the HCQ + Z-max + Zinc remedy for sale over the counter. Here is a petition to the WhiteHouse to allow HCQ to be sold over the counter. Please sign it if you are concerned about saving lives. According to the Ford study treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System. The death rate was cut in half for patients treated with HCQ. It it even more dramatic if HCQ is administered as soon as symptoms occur, over 40 international studies have shown an up to 80+% reduction in death rates. For some reason FDA and CDC do not acknowledge international studies.
August 10, 2020 (LifeSiteNews) author: Stephen Mosher – It will not be possible for the Dr. Fauci’s of the world to dismiss Professor Giuseppe Tritto as a crank. Not only is he an internationally known expert in biotechnology and nanotechnology who has had a stellar academic career, but he is also the president of the World Academy of Biomedical Sciences and Technologies (WABT), an institution founded under the aegis of UNESCO in 1997.
In other words, he is a man of considerable stature in the global scientific community. Equally important, one of the goals of WABT is to analyze the effect of biotechnologies—like genetic engineering—on humanity.
In his new book, this world-class scientist does exactly that. And what he says is that the China Virus definitely wasn’t a freak of nature that happened to cross the species barrier from bat to man. It was genetically engineered in the Wuhan Institute of Virology’s P4 (high-containment) lab in a program supervised by the Chinese military.
Prof. Tritto’s book, which at present is available only in Italian, is called Cina COVID 19: La Chimera che ha cambiato il Mondo(China COVID 19: The chimera that changed the world). It was published on August 4 by a major Italian press, Edizioni Cantagalli, which coincidently also published the Italian edition of one of Stephen Mosher’s books, Population Control (Controllo Demografico in Italian) several years ago.
What sets Prof. Tritto’s book apart is the fact that it demonstrates—conclusively, in Stephen Mosher’s view—the pathway by which a PLA-owned coronavirus was genetically modified to become the China Virus now ravaging the world. His account leaves no doubt that it is a “chimera”, an organism created in a lab.
He also connects the dots linking the Wuhan lab to France and the United States, showing how both countries provided financial and scientific help to the Chinese as they began to conduct ever more dangerous bioengineering experiments. Although neither American nor French virologists are responsible for the end result—a highly infectious coronavirus and a global pandemic—their early involvement may explain why so many insist that the “chimera” must have come from nature. The last thing they want to admit is that they might have had a hand in it.
In 2015 President Barack Obama, Dr. Anthony Fauci and Melinda Gates visited the Wuhan lab after giving a 3.5 million research grant to study bat viruses and maybe develop a vaccine against it. At some other forum he also said ” there is “no doubt” Donald J. Trump will be confronted with a surprise infectious disease outbreak during his presidency.”
Those of us who, early on, argued for a laboratory origin were dismissed as conspiracy theorists. Our articles were censored as “fake news,” often by American virologists who knew perfectly well what the truth was, but preferred to protect China, and themselves, from scrutiny lest they themselves be implicated.
Dr. Tritto’s 272 pages of names, dates, places, and facts leaves such apologists with no place to hide. The story begins following the SARS epidemic of 2003, as the Chinese attempt to develop vaccines to combat the deadly disease. Dr. Shi Zhengli, about whom I have previously written, was in charge of the program at the Wuhan Institute of Virology.
In vaccine development, reverse genetics is used to create viral strains that have reduced pathogenicity but to which the immune system responds by creating antibodies against the virus. But reverse genetics can also be used to create viral strains that have increased pathogenicity. That is what Dr. Shi, encouraged by PLA bioweapons experts, began increasingly to focus her research on, according to Prof. Tritto.
Dr. Shi first solicited help from the French government, which built the P4 lab, and from the country’s Pasteur institute, which showed her how to manipulate HIV genomes. The gene insertion method used is called “reverse genetics system 2.” Using this method, she inserted an HIV segment into a coronavirus discovered in horseshoe bats to make it more infectious and lethal.
The U.S. was involved as well, particularly Prof Ralph S. Baric, of the University of North Carolina, who was on the receiving end of major grants from the National Institute of Allergy and Infectious Disease. This is, of course, Dr. Anthony Fauci’s shop. Fauci was a big proponent of “gain of function” research, and when this was prohibited at Baric’s lab because it was considered to be too dangerous, the research was shifted to China.
Prof. Tritto believes that, while Dr. Shi’s research began as an effort to develop a vaccine against SARS, it gradually morphed into an effort to use “reverse genetics” to build lethal biological weapons. This was the reason that the Wuhan lab became China’s leading center for virology research in recent years, attracting major funding and support from the central government.
Stephen Mosher would add that the rule in Communist-controlled China is “let the civilian support the military,” which means that as soon as Dr. Shi’s research showed any potential military uses the PLA would have begun exercising control of the research. This came out in the open with the outbreak, when China’s leading expert on bioweapons, People’s Liberation Army Major General Chen Wei, was immediately placed in charge of the Wuhan Institute of Virology. As for Dr. Shi Zheng-Li, she seems to have disappeared.
As Dr. Tritto explained in an interview with Italian media:
In 2005, after the SARS epidemic, the Wuhan Institute of Virology was born, headed by Dr. Shi Zheng-Li, who collects coronaviruses from certain bat species and recombines them with other viral components in order to create vaccines. In 2010 she came into contact with American researchers led by Prof. Ralph Baric, who in turn works on recombinant viruses based on coronaviruses. Thanks to the matrix viruses provided by Shi, Baric created in 2015 a mouse Sars-virus chimera, which has a pathogenic effect on human cells analyzed in vitro.
At that point, the China-US collaboration becomes competition. Shi wants to work on a more powerful virus to make a more powerful vaccine: it combines a bat virus with a pangolin virus in vitro and in 2017 publishes the results of this research in some scientific articles.
Her research attracts the interest of the Chinese military and medical-biological sector which deals with biological weapons used as a deterrent for defensive and offensive purposes. Thus Shi is joined by doctors and biologists who belong to the political-military sphere, such as Guo Deyin, a scholar of anti-AIDS and anti-viral hepatitis vaccines and expert in genetic recombination techniques. The introduction of the new engineered inserts into the virus genome is the result of the collaboration between the Shi team and that of Guo Deyin. The realization of this new chimera, from a scientific point of view, is a success. So much so that, once the epidemic has broken out, the two researchers ask WHO to register it as a new virus, H-nCoV-19 (Human new Covid 19), and not as another virus derived from SARS. It is reasonable to think that Shi acted only from the point of view of scientific prestige, without however taking into account the risks in terms of security and the political-military interests that her research would have aroused.
When asked why China has refused to provide the complete genome of the China Virus to the WHO or to other countries, Dr. Tritto explained that “providing the matrix virus would have meant admitting that SARS-CoV-2 [China Virus] was created in the laboratory. In fact, the incomplete genome made available by China lacks some inserts of AIDS amino acids, which itself is a smoking gun.”
The key question, for those of us who are living through the pandemic, concerns the development of a vaccine. On this score, Prof. Tritto is not optimistic:
Given the many mutations of SARS-CoV-2, it is extremely unlikely that a single vaccine that blocks the virus will be found. At the moment 11 different strains have been identified: the A2a genetic line which developed in Europe and the B1 genetic line which took root in North America are more contagious than the 0 strain originating in Wuhan. I therefore believe that, at the most, a multivalent vaccine can be found effective on 4-5 strains and thus able to cover 70-75% of the world’s population.
In other words, by withholding from the world the original genetic code of the China Virus that it created, the Chinese Communist Party is ensuring that no completely effective vaccine will ever be developed by the West.
In other words, China continues to lie, and people continue to die.
Steven W. Mosher @StevenWMosher is the President of the Population Research Institute and the author of Bully of Asia: Why China’s “Dream” is the New Threat to World Order.
The Swedish Medical Products Agency, Läkemedelsverket, stopped the use of hydroxychloroquine and chloroquine against the China virus on April 2, 2020, until October 31, 2020. Had these medications remained available for prescription by a general physician the death rates would have gone down, probably by about 50% according to over 40 international studies. This assumes medication would have been prescribed as soon as symptoms arose.
Their excuse: “The Medical Products Agency has received signals of a sharp increase in prescribing of chloroquine, which is judged to be related to the outbreak of covid-19. The drug is relevant in several ongoing clinical trials against covid-19. To counteract a shortage situation, a new regulation will limit prescribing to doctors with certain specialist competencies, as well as limiting the dispensing of the medicine.”
In other words: We don’t care if people die before our clinical trials are complete.
But to show heart, they add: “An approved drug containing hydroxychloroquine may be dispensed against a prescription from a pharmacy only if it has been prescribed by a doctor with specialist competence in rheumatology, skin and sexually transmitted diseases or pediatric and adolescent medicine.”
The SARS-Coronavirus appeared first in China in 2002. It spread rapidly, and NIH tried to develop a vaccine it disappeared. What they found instead was that chloroquine (same as hydroxychloroquine, but with more side-effects) was an effective anti-virus fighter, so effective that it could completely abolish the SARS-Covid infection. This was in 2005
Fast forward to 2020. This time they were not going to let the cure get established before the vaccine. Hydroxychloroquine + Zinc + Zitromax is an effective cure if taken as soon as symptoms occur. HCQ by itself is a good prophylactic, completely safe for nearly everybody (even for pregnant women and nursing mothers), and has been approved for Lupus and rheumatoid arthritis for many years without problem. These people take HCQ forever.
It is time to provide HCQ as an over the counter drug.
We are making great strides in the fight against the corona-virus. In the beginning the disease had an 8,67% death rate. It is now down to 2.19%.
The corresponding numbers for U.S.A : 7.02% death rate at the beginning of the disease. Ir is now down to 1.53%, a 78% decrease. With unrestricted availability to take HCQ+ we can reduce the death rate even further.
These are the numbers for every state.
State Death rate max 7 day death rate now
Connecticut 9.62% 3.22%
New Hampshire 9.33% 5.2%
Missouri 8.96% 0.86% Prescribing hydroxychloroquine, chloroquine, and azithromycin for COVID-19 prophylactic is discouraged and not recommended. Prescribers include the diagnosis code or diagnosis with the prescription. Prescribers should consider limiting the amount prescribed.
Pennsylvania 8.81% 1.63%
Indiana 8.77% 1.39%
New Jersey 8.73% 4.23%
New York State 8.64% 1.79% Positive COVID-19 test result must be documented as part of the prescription.•Prohibits use of hydroxychloroquine or chloroquine for experimental or prophylactic use.
Michigan 8.58% 0.92%
South Carolina 8.52% 3.09%
Kansas 7.69% 1.30% Strongly encourages vigilance in processing new prescriptions for chloroquine and hydroxychloroquine •Recommends that if used, chloroquine and hydroxychloroquine should be restricted to patients who are admitted to hospitals with COVID-19 infections.•Urges pharmacists to consider that patients currently taking hydroxychloroquine for FDA-approved indications (lupus, rheumatoid arthritis) could be affectedby increased prescribing and that supplies should be monitored by pharmacists for medication availability.•Recommends reaching out to prescribers to verify COVID-19 diagnosis.
West Virginia 7.68% 1.1%
Arizona 7.62% 3.08%
Nevada 7.53% 1.55% Restricts the dispensing of chloroquine and hydroxychloroquine. The patient must have a diagnosis of COVID-19 and the diagnosis is indicated on the prescription;
D.C. 7.45% 0.86%
Oklahoma 7.29% 0.65%
Massachusetts 7.24% 4.55%
New Mexico 7.14% 1.97%
Maine 7% 2%
Mississippi 7.06% 1.62%
Wisconsin 6.97% 0.93%
Colorado 6.96% 1.28%
Rhode Island 6.92% 0.88%
Alabama 6.61% 1.21%
Delaware 6.55% 2%
Maryland 6.16% 1.10%
Washington 5.69% 1.10%
Georgia 5.24% 1.23%
Kentucky 5.02% 0.93% Prescriptions for chloroquine, hydroxychloroquine, mefloquine, and azithromycin may only be dispensed if: The prescription bears a written diagnosis from the prescriber consistent with its use;
Ohio 4.97% 1.93% Prescriptions for either presumptive positive patients or prophylactic use of chloroquineor hydroxychloroquine related to COVID-19 is strictly prohibited unless the drugs are for use as part of a documented institutional review board-approved clinical trial to evaluate the safety and efficacy of the drugs to treat COVID-19
California 4.82% 1.47%
Arkansas 4.70% 1.20%
Oregon 4.66% 1.76%
Illinois 4,66% 1.12%
North Carolina 4.47% 1.27% Rule applies to hydroxychloroquine, chloroquine, lopinavir-ritonavir, ribavirin, darunavir, and azithromycin;•For above drugs, a pharmacist can only fill or refill a prescription if that prescription bears a written diagnosis from the prescriber consistent with its evidence for use;•If a patient has been diagnosed with COVID-19, any prescription of a drug listed above for the treatment of COVID-19 must: Indicate on the prescription that the patient has been diagnosed with COVID-19
Louisiana 4.18% 1.85% The boardoriginally issued an emergency rule to limit the dispensing of chloroquine and hydroxychloroquine to address shortages,but rescinded the rule after it received information about a significant donation and distribution of the drugs from the manufacturer, along with the removal of the drug from FDA’s drug shortage list.•It now encourages each pharmacy to exercise professional discretion to dispense limited quantities of the drug as appropriate
Florida 4.02% 1.75%
Montana 4% 1.4%
Idaho 3.70% 1.21% No prescription for chloroquine or hydroxychloroquine may be dispensed except if the following apply: The prescription bears a written diagnosis from the prescriber consistent with evidence for its use;
Vermont 3.6% 1%
Texas 3.60% 2.56% No prescription or medication order for chloroquine, hydroxychloroquine, mefloquine or azithromycin may be dispensed or distributed unless all the following apply:oThe prescription or medication order bears a written diagnosis from the prescriber consistent with the evidence for its use; The prescription or medication order is limited to no more than a 14-day supply unless the patient was previously established on the medication; and no refills may be permitted unless a new prescription or medication order is furnished
North Dakota 3.6% 0.8%
Minnesota 3.55% 0.70%
Tennessee 3.50% 0,71%
Alaska 3.5% 1%
Iowa 2.95% 1.27%
Hawaii 2.8% 0.5%
Virginia 2.76% 1.40%
Utah 1.66% 0.97%
South Dakota 1.1% 1.25%
Wyoming 1% 0.5%
Nebraska 0.82% 0.72%
For all states, June 15, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19 when a clinical trial was unavailable, or participation in a clinical trial was not feasible. The agency determined that the legal criteria for issuing an EUA are no longer met. Based on its ongoing analysis of the EUA and emerging scientific data, the FDA determined that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA.
By the time the patient is hospitalized it may be too late to have any benefit of HCQ+ treatment. It works best as a prophylactic or taken as soon as the telltale sign occurs, loss of taste and smell, shortness of breath, etc. Then is the time to start the HCQ + Zn + Zmax treatment, even before a positive diagnosis is established.
Release HCQ to be sold as over the counter medication. For LUPUS and rheumatorial arthritis patients it is even prescribed to pregnant women and nursing mothers. It is that safe.
Here is the petition to the WhiteHouse to release it to over the counter dispensation. (19287 signed so far)
“The scientific data is really quite evident now about the lack of efficacy for it,” Fauci, a key medical adviser on the White House coronavirus task force, told CNN’s Jim Sciutto on “Newsroom” of the drug, adding that there’s likelihood of “adverse events with regard to cardiovascular.”
Dr Fauci, how do you explain the excellent results in more than 10 countries, where HCQ is taken (Sometimes together with Azithromycine and sometimes with added Zinc) as soon as COVID-19 symptoms shows up, sometimes before a positive test is confirmed?
This is a very interesting chart:
But wait. Not so fast. These countries may have a younger population, and the death rate is much lower for younger people. This chart tells the relative death rate, and it shows that with the advent of the coronavirus the death risk doubled regardless of the age of the victim.
The death rate doubles for every 8 years as you age or about 9% per year. The world median age is 30.4 years. So let the world death rate be the norm
World death rate as of May 21 is 6.42% of diagnosed cases. and recovered cases versus deaths is 7.05
Compare this with 10 countries that use HCQ for most patients as soo as they test positive for the corona virus.
Turkey: Death rate 2.84%, median age 30.9, adjusted death rate 2.72%, recovered cases versus deaths 27.7
South Korea: Death rate 2.37%, median age 30.9, adjusted death rate 2.26% recovered cases versus deaths 38.4
Malaysia: Death rate 1.51%, median age 28.5, adjusted death rate 1.74% recovered cases versus deaths 53.6
Senegal: Death rate 1.16%, median age 18.8, adjusted death rate 3.10%, recovered cases versus deaths 43.2
Costa Rica: Death rate 1.02%, median age 31.3, adjusted death rate 0.95%, recovered cases versus deaths 63.9
United Arab emirates: Death rate 0.80%, median age 30.9, adjusted death rate 0.77%, recovered cases versus deaths 64.7
Bahrain: Death rate 1.50%, median age 32.3, adjusted death rate 1.30%, recovered cases versus deaths 353.0
Morocco: Death rate 2.65%, median age 29.3, adjusted death rate 2.88%, recovered cases versus deaths 25.3
Russia: Death rate 1.00%, median age 30.9, adjusted death rate 0.95%, recovered cases versus deaths 36.5
Qatar: Death rate 0.07%, median age 30.9, but since 88% of the population are migrant workers between 20 and 60, the adjusted death rate is at least 8 times higher, or 0.56 %, and recovered cases versus deaths 466.3
Taking the average, not adjusted for the size of the populations we get the average adjusted death rate for countries, where people are taking HCQ + Zinc when diagnosed positive, is 1.89%.
This means that the risk of death is reduced by a factor of 3.4 if HZQ + Zinc is taken as early as possible after a positive diagnosis for coronavirus!
Recovered cases versus deaths is an indicator of how fast patients recover after taking HCQ. Taking the arithmetic average would be unfair, so here I show the median recovery ratio, or about 40, compared to the recovery rate for the rest of the world of 7.05, an improvement of 5.6 times as many earlier recoveries.
What are we waiting for, and what is your concern, Dr Fauci? Hydroxychloroquine is approved for Malaria, Lupus and Rheumatoid Arthritis, and is used by millions or people world wide with normal precautions. There are side-effects, but death is not one listed, and the cardiac concern is taken care of with a simple ECG, disqualifying less than 1% of the patients.
WHO paused a double blind study out of an “abundance of caution”.
The five worst and the five best states of Covid-19 death rates versus percent of population tested:
Michigan 9.48% death rate and 2.4% of population tested
2. Connecticut 8,87% 3.1%
3. New York 7.80% 5.6%
4. Lousiana 7.23% 4.4%
5. New Jersey 6.55% 4.4%
46. Tennessee 1.66% 3.4%
47. Nebraska 1.17% 2.0%
48. Wyoming 1.08% 2.1%
49. Utah 1.03% 4.3%
50. South Dakota 0.98% 2.4%
Beside from the obvious fact that the five worst states are all run by Democrat Governors and the five best state are all run by Republicans, these are my observations:
Michigan has a Detroit problem. The COVID-19 death rate there is over 10%, many got turned away from the few hospitals and were sent home without first being tested. Governor Gretchen Whitmer seems more interested in controlling the healthy population than to protect the vulnerable.
Why Connecticut is second on the list I don’t know, but Hartford County has a problem with a death rate over 10%
The problem with New York is that Governor Cuomo ordered nursing home facilities to accept COVID-19 patients, they are not set up to handle highly contagious patients, and so the infection and death rate among the most vulnerable population skyrocketed. One interesting statistics is that two thirds of all New York COVID-19 cases were from people staying home, not going out at all.
The problem with Louisiana is that it let Mardi Gras proceed and people came, did their thing and went back to where they came from, often to under-served areas.
New Jersey is next to New York. Need I say more?
On the other hand, the five best states concentrated their efforts to protect the at risk people, concentrating on hygiene and social distancing rather than trying to micromanage the healthy population. There seem to be no improvement in the outcome by adding testing. In addition the death rate among the five worst states is still rising, whereas the death rate in the five best states is declining.
Governor Kristi Noem of South Dakota, the state with the best outcome so far did order a clinical test of using the combination Hydroxychloroquine + Azithromycin + Zinc for five days and that may be the reason the death rate is less than 1 percent. Unfortunately the FDA is concerned that hydroxychloroquine and chloroquine are being used inappropriately to treat non-hospitalized patients for coronavirus disease (COVID-19) or to prevent that disease. Quote:” We authorized their temporary use only in hospitalized patients with COVID-19 when clinical trials are not available, or participation is not feasible, through an Emergency Use Authorization (EUA). These medicines have a number of side effects, including serious heart rhythm problems that can be life-threatening.”
Here is my suggestion: Issue an executive order opening up a clinical study in the effectiveness of COVID-19 treatment with Hydroxychloroquine + Azithromycin + Zinc for five days, and open it up to any qualified Physician or Nurse Practitioner who want to participate. They do the heart test, check for other ailments and report the results to a central data base and a follow up report, and even if it is not a double blind study, once you have a million or so results the FDA can approve the medication. In the meantime over 90% of the patients were getting better, and hopefully nobody had given it to patients with severe preexisting heart conditions. The risk is minimal. It is already approved for Lupus, Rheumatism and Malaria, and the same protocol should apply here.
It is very important the drug is administered as early as possible. By the time the patient is admitted to a hospital it may be too late. Especially if the patient is already on a ventilator it may do more harm than good.
Why is this study even necessary? This medication is too cheap, it is generic, so no pharmaceutical company is willing to foot the bill on something unprofitable, so it must be done by a university or through a government agency.
It is not that daring a thing to do. Here is a result of a COVID-19 study with more than 6,200 physicians in 30 countries.
The three most commonly prescribed treatments among COVID-19 treaters are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine
Hydroxychloroquine usage among COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK and 7% in Japan
Hydroxychloroquine was overall chosen as the most effective therapy among COVID-19 treaters from a list of 15 options (37% of COVID-19 treaters)
75% in Spain, 53% Italy, 44% in China, 43% in Brazil, 29% in France, 23% in the U.S. and 13% in the U.K.
The two most common treatment regimens for Hydroxychloroquine were:
(38%) 400mg twice daily on day one; 400 mg daily for five days
(26%) 400mg twice daily on day one; 200mg twice daily for four days
Outside the U.S., Hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients
Globally, 19% of physicians prescribed or have seen Hydroxychloroquine prophylactically used for high risk patients, and 8% for low risk patients.
And this is a very recent tweet from president Donald Trump, without which frequent and persistent recommendation this drug combination would have already been approved, as it is in at least 12 other countries.